Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

DIS3L Inhibitors

DIS3L inhibitors represent a specialized class of compounds that target the DIS3-like exonuclease, a member of the exosome complex responsible for RNA degradation. The DIS3L protein is a paralog of DIS3, sharing structural similarities but with distinct substrate preferences and biological roles. Both proteins are part of the RNA exosome complex, which is essential for processing and degrading various RNA species within the cell, including mRNA, rRNA, and small nuclear RNAs (snRNA). By inhibiting DIS3L, compounds in this class affect the regulation of RNA metabolism, specifically through their action on exoribonucleolytic activity. The core function of DIS3L is associated with 3'-5' exonucleolytic degradation, meaning it processes RNA molecules by trimming them from their 3' end towards the 5' end, maintaining cellular RNA homeostasis.

The chemical structures of DIS3L inhibitors are typically designed to mimic substrates of the DIS3L exonuclease or to bind at its active site in such a way that disrupts its enzymatic function. This disruption can lead to alterations in RNA processing and degradation, which in turn impacts the regulation of gene expression. Structurally, these inhibitors often contain moieties that interact with metal ions such as magnesium or manganese, which are necessary cofactors for the catalytic activity of DIS3L. By interfering with the coordination of these metal ions or directly occupying the enzyme's active site, DIS3L inhibitors can block the hydrolytic mechanism that normally breaks down RNA strands. The specificity of these inhibitors is critical, as targeting the exonuclease in a precise manner is necessary to achieve the desired alteration in RNA metabolism without affecting other components of the RNA exosome complex.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D inhibits RNA polymerase, affecting RNA synthesis and potentially impacting DIS3L's role in RNA turnover.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

5-Fluorouracil inhibits thymidylate synthase, impacting RNA processing and stability, potentially influencing DIS3L.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin causes DNA damage, potentially influencing transcription and subsequent RNA turnover involving DIS3L.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB inhibits RNA polymerase II phosphorylation, affecting mRNA synthesis and possibly DIS3L activity.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Cordycepin, an adenosine analog, inhibits RNA synthesis, potentially impacting DIS3L-mediated RNA degradation.

Spliceostatin A

391611-36-2sc-507481
1 mg
$1800.00
(0)

Spliceostatin A affects mRNA splicing, potentially altering the types of RNA substrates available for DIS3L.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Doxorubicin, an anthracycline antibiotic, causes DNA damage, potentially influencing RNA processing and DIS3L activity.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$69.00
$266.00
8
(1)

Mycophenolic Acid inhibits inosine monophosphate dehydrogenase, potentially impacting RNA synthesis and DIS3L activity.